Increasing Cardiomyocyte Atrogin-1 Reduces Aging-Associated Fibrosis and Regulates Remodeling in Vivo

Roberto Mota, Traci L. Parry, Cecelia C. Yates, Zhaoyan Qiang, Samuel C. Eaton, Jean Marie Mwiza, Deepthi Tulasi, Jonathan C. Schisler, Cam Patterson, Tania Zaglia, Marco Sandri, Monte Willis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The muscle-specific ubiquitin ligase atrogin-1 (MAFbx) has been identified as a critical regulator of pathologic and physiological cardiac hypertrophy; it regulates these processes by ubiquitinating transcription factors [nuclear factor of activated T-cells and forkhead box O (FoxO) 1/3]. However, the role of atrogin-1 in regulating transcription factors in aging has not previously been described. Atrogin-1 cardiomyocyte-specific transgenic (Tg + ) adult mice (α-major histocompatibility complex promoter driven) have normal cardiac function and size. Herein, we demonstrate that 18-month-old atrogin-1 Tg + hearts exhibit significantly increased anterior wall thickness without functional impairment versus wild-type mice. Histologic analysis at 18 months revealed atrogin-1 Tg + mice had significantly less fibrosis and significantly greater nuclei and cardiomyocyte cross-sectional analysis. Furthermore, by real-time quantitative PCR, atrogin-1 Tg + had increased Col 6a4, 6a5, 6a6, matrix metalloproteinase 8 (Mmp8), and Mmp9 mRNA, suggesting a role for atrogin-1 in regulating collagen deposits and MMP-8 and MMP-9. Because atrogin-1 Tg + mice exhibited significantly less collagen deposition and protein levels, enhanced Mmp8 and Mmp9 mRNA may offer one mechanism by which collagen levels are kept in check in the aged atrogin-1 Tg + heart. In addition, atrogin-1 Tg + hearts showed enhanced FoxO1/3 activity. The present study shows a novel link between atrogin-1–mediated regulation of FoxO1/3 activity and reduced collagen deposition and fibrosis in the aged heart. Therefore, targeting FoxO1/3 activity via the muscle-specific atrogin-1 ubiquitin ligase may offer a muscle-specific method to modulate aging-related cardiac fibrosis.

Original languageEnglish (US)
Pages (from-to)1676-1692
Number of pages17
JournalAmerican Journal of Pathology
Volume188
Issue number7
DOIs
StatePublished - Jul 1 2018

Fingerprint

Cardiac Myocytes
Fibrosis
Collagen
Matrix Metalloproteinase 8
Ligases
Ubiquitin
Matrix Metalloproteinases
Muscles
Transcription Factors
NFATC Transcription Factors
Messenger RNA
Cardiomegaly
Major Histocompatibility Complex
Real-Time Polymerase Chain Reaction
Cross-Sectional Studies
Proteins
rat Fbxo32 protein

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Increasing Cardiomyocyte Atrogin-1 Reduces Aging-Associated Fibrosis and Regulates Remodeling in Vivo. / Mota, Roberto; Parry, Traci L.; Yates, Cecelia C.; Qiang, Zhaoyan; Eaton, Samuel C.; Mwiza, Jean Marie; Tulasi, Deepthi; Schisler, Jonathan C.; Patterson, Cam; Zaglia, Tania; Sandri, Marco; Willis, Monte.

In: American Journal of Pathology, Vol. 188, No. 7, 01.07.2018, p. 1676-1692.

Research output: Contribution to journalArticle

Mota, R, Parry, TL, Yates, CC, Qiang, Z, Eaton, SC, Mwiza, JM, Tulasi, D, Schisler, JC, Patterson, C, Zaglia, T, Sandri, M & Willis, M 2018, 'Increasing Cardiomyocyte Atrogin-1 Reduces Aging-Associated Fibrosis and Regulates Remodeling in Vivo', American Journal of Pathology, vol. 188, no. 7, pp. 1676-1692. https://doi.org/10.1016/j.ajpath.2018.04.007
Mota, Roberto ; Parry, Traci L. ; Yates, Cecelia C. ; Qiang, Zhaoyan ; Eaton, Samuel C. ; Mwiza, Jean Marie ; Tulasi, Deepthi ; Schisler, Jonathan C. ; Patterson, Cam ; Zaglia, Tania ; Sandri, Marco ; Willis, Monte. / Increasing Cardiomyocyte Atrogin-1 Reduces Aging-Associated Fibrosis and Regulates Remodeling in Vivo. In: American Journal of Pathology. 2018 ; Vol. 188, No. 7. pp. 1676-1692.
@article{861afc9af4ab4513aa2dfb205f663ea2,
title = "Increasing Cardiomyocyte Atrogin-1 Reduces Aging-Associated Fibrosis and Regulates Remodeling in Vivo",
abstract = "The muscle-specific ubiquitin ligase atrogin-1 (MAFbx) has been identified as a critical regulator of pathologic and physiological cardiac hypertrophy; it regulates these processes by ubiquitinating transcription factors [nuclear factor of activated T-cells and forkhead box O (FoxO) 1/3]. However, the role of atrogin-1 in regulating transcription factors in aging has not previously been described. Atrogin-1 cardiomyocyte-specific transgenic (Tg + ) adult mice (α-major histocompatibility complex promoter driven) have normal cardiac function and size. Herein, we demonstrate that 18-month-old atrogin-1 Tg + hearts exhibit significantly increased anterior wall thickness without functional impairment versus wild-type mice. Histologic analysis at 18 months revealed atrogin-1 Tg + mice had significantly less fibrosis and significantly greater nuclei and cardiomyocyte cross-sectional analysis. Furthermore, by real-time quantitative PCR, atrogin-1 Tg + had increased Col 6a4, 6a5, 6a6, matrix metalloproteinase 8 (Mmp8), and Mmp9 mRNA, suggesting a role for atrogin-1 in regulating collagen deposits and MMP-8 and MMP-9. Because atrogin-1 Tg + mice exhibited significantly less collagen deposition and protein levels, enhanced Mmp8 and Mmp9 mRNA may offer one mechanism by which collagen levels are kept in check in the aged atrogin-1 Tg + heart. In addition, atrogin-1 Tg + hearts showed enhanced FoxO1/3 activity. The present study shows a novel link between atrogin-1–mediated regulation of FoxO1/3 activity and reduced collagen deposition and fibrosis in the aged heart. Therefore, targeting FoxO1/3 activity via the muscle-specific atrogin-1 ubiquitin ligase may offer a muscle-specific method to modulate aging-related cardiac fibrosis.",
author = "Roberto Mota and Parry, {Traci L.} and Yates, {Cecelia C.} and Zhaoyan Qiang and Eaton, {Samuel C.} and Mwiza, {Jean Marie} and Deepthi Tulasi and Schisler, {Jonathan C.} and Cam Patterson and Tania Zaglia and Marco Sandri and Monte Willis",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.ajpath.2018.04.007",
language = "English (US)",
volume = "188",
pages = "1676--1692",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Increasing Cardiomyocyte Atrogin-1 Reduces Aging-Associated Fibrosis and Regulates Remodeling in Vivo

AU - Mota, Roberto

AU - Parry, Traci L.

AU - Yates, Cecelia C.

AU - Qiang, Zhaoyan

AU - Eaton, Samuel C.

AU - Mwiza, Jean Marie

AU - Tulasi, Deepthi

AU - Schisler, Jonathan C.

AU - Patterson, Cam

AU - Zaglia, Tania

AU - Sandri, Marco

AU - Willis, Monte

PY - 2018/7/1

Y1 - 2018/7/1

N2 - The muscle-specific ubiquitin ligase atrogin-1 (MAFbx) has been identified as a critical regulator of pathologic and physiological cardiac hypertrophy; it regulates these processes by ubiquitinating transcription factors [nuclear factor of activated T-cells and forkhead box O (FoxO) 1/3]. However, the role of atrogin-1 in regulating transcription factors in aging has not previously been described. Atrogin-1 cardiomyocyte-specific transgenic (Tg + ) adult mice (α-major histocompatibility complex promoter driven) have normal cardiac function and size. Herein, we demonstrate that 18-month-old atrogin-1 Tg + hearts exhibit significantly increased anterior wall thickness without functional impairment versus wild-type mice. Histologic analysis at 18 months revealed atrogin-1 Tg + mice had significantly less fibrosis and significantly greater nuclei and cardiomyocyte cross-sectional analysis. Furthermore, by real-time quantitative PCR, atrogin-1 Tg + had increased Col 6a4, 6a5, 6a6, matrix metalloproteinase 8 (Mmp8), and Mmp9 mRNA, suggesting a role for atrogin-1 in regulating collagen deposits and MMP-8 and MMP-9. Because atrogin-1 Tg + mice exhibited significantly less collagen deposition and protein levels, enhanced Mmp8 and Mmp9 mRNA may offer one mechanism by which collagen levels are kept in check in the aged atrogin-1 Tg + heart. In addition, atrogin-1 Tg + hearts showed enhanced FoxO1/3 activity. The present study shows a novel link between atrogin-1–mediated regulation of FoxO1/3 activity and reduced collagen deposition and fibrosis in the aged heart. Therefore, targeting FoxO1/3 activity via the muscle-specific atrogin-1 ubiquitin ligase may offer a muscle-specific method to modulate aging-related cardiac fibrosis.

AB - The muscle-specific ubiquitin ligase atrogin-1 (MAFbx) has been identified as a critical regulator of pathologic and physiological cardiac hypertrophy; it regulates these processes by ubiquitinating transcription factors [nuclear factor of activated T-cells and forkhead box O (FoxO) 1/3]. However, the role of atrogin-1 in regulating transcription factors in aging has not previously been described. Atrogin-1 cardiomyocyte-specific transgenic (Tg + ) adult mice (α-major histocompatibility complex promoter driven) have normal cardiac function and size. Herein, we demonstrate that 18-month-old atrogin-1 Tg + hearts exhibit significantly increased anterior wall thickness without functional impairment versus wild-type mice. Histologic analysis at 18 months revealed atrogin-1 Tg + mice had significantly less fibrosis and significantly greater nuclei and cardiomyocyte cross-sectional analysis. Furthermore, by real-time quantitative PCR, atrogin-1 Tg + had increased Col 6a4, 6a5, 6a6, matrix metalloproteinase 8 (Mmp8), and Mmp9 mRNA, suggesting a role for atrogin-1 in regulating collagen deposits and MMP-8 and MMP-9. Because atrogin-1 Tg + mice exhibited significantly less collagen deposition and protein levels, enhanced Mmp8 and Mmp9 mRNA may offer one mechanism by which collagen levels are kept in check in the aged atrogin-1 Tg + heart. In addition, atrogin-1 Tg + hearts showed enhanced FoxO1/3 activity. The present study shows a novel link between atrogin-1–mediated regulation of FoxO1/3 activity and reduced collagen deposition and fibrosis in the aged heart. Therefore, targeting FoxO1/3 activity via the muscle-specific atrogin-1 ubiquitin ligase may offer a muscle-specific method to modulate aging-related cardiac fibrosis.

UR - http://www.scopus.com/inward/record.url?scp=85048836945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048836945&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2018.04.007

DO - 10.1016/j.ajpath.2018.04.007

M3 - Article

C2 - 29758183

AN - SCOPUS:85048836945

VL - 188

SP - 1676

EP - 1692

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 7

ER -